Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Equity (2016 - 2025)

Cumberland Pharmaceuticals' Return on Equity history spans 15 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Equity rose 16.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 16.0%, while the annual FY2025 figure was 0.12%, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 0.11% at Cumberland Pharmaceuticals, up from 0.12% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.06% in Q1 2021 and bottomed at 0.27% in Q4 2024.
  • The 5-year median for Return on Equity is 0.0% (2023), against an average of 0.05%.
  • The largest annual shift saw Return on Equity dropped -22bps in 2024 before it increased 16bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.04% in 2021, then tumbled by -71bps to 0.01% in 2022, then tumbled by -106bps to 0.0% in 2023, then crashed by -34152bps to 0.27% in 2024, then surged by 59bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Return on Equity are 0.11% (Q4 2025), 0.12% (Q3 2025), and 0.1% (Q2 2025).